SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Mylan Labs
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
384 7 0 MYL
Emcee:  Brett Koplin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
134 harkenman, NBR mentioned Ivax and Mylan. The president of Andrex was interviewMartin Wormser-8/10/1997
133 I think NBR talked about IVAX and Roberts. I'll try to find the segment onMartin Wormser-8/10/1997
132 Did they have any thing to say about Barr Labs or IVAX?harkenman-8/10/1997
131 CNBC and NBR did special reports on the generic drug industry. Mylan was featuMartin Wormser-8/10/1997
130 Mylan was around $25 two years ago when the outlook was not even anywhere as soBob Swift-8/6/1997
129 Mylan has absolutely no debt, is undervalued at current levels and has solid reChristopher Nicora-8/5/1997
128 Good news: Earnings estimates raised! Dillon, Read said analyst Jerry Treppel Jim Land-8/5/1997
127 giles, Don't know about the takeover. Mylan is a 32 year old company with sMartin Wormser-8/5/1997
126 May not have gone up on takeover rumors although I found no news items yet to egiles-8/5/1997
125 Harkenman, Up over 3 today. Was 15 on July 19. I don't know why anybody Martin Wormser-8/5/1997
124 Why buy a generic company when there so many out there and the margins suck. Lharkenman-8/5/1997
123 All shareholders were recently asked to complete a form that would make it moreChristopher Nicora-8/4/1997
122 Patent expired for Procardia (Composition) in 1989, the capsule form expired inharkenman-7/28/1997
121 NEW YORK, July 28 (Reuter) - Gruntal & Co said it upgraded Mylan LaboraDavid Lawrence-7/28/1997
120 Hark, You know a great deal about the generic industry, tell me what margins wJames Silverman-7/25/1997
119 <i>>>Procardia XL, Zantac It seems that MYL has lost its ability toDavid Lawrence-7/25/1997
118 Procardia XL, Zantac It seems that MYL has lost its ability to develop genericsharkenman-7/25/1997
117 New Strategy? Mylan Labs In Pact To Distribute Generic Form Of Zantac PITTSBharkenman-7/25/1997
116 Pfizer (Procardia XL marketer) sued the FDA in regards to the ANDA from MYL-thJames Silverman-7/25/1997
115 Myl does seem to know how to make money in a "me-too" environment. WKenneth E. De Paul-7/24/1997
114 Hark, You're being awfully harsh on MYL. If Procardia is so easy to copy,James Silverman-7/23/1997
113 The earnings looked good for a change. Maybe there is a turnaround we are missKenneth E. De Paul-7/23/1997
112 Procardia is just a sustained release product which can be mimicked by anyone harkenman-7/22/1997
111 Hark, I don't own any shares of MYL, but in light of your never ending negJames Silverman-7/21/1997
110 good question.Epics-7/21/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News